Sichenzia Ross Friedman Ference LLP Represents Israeli Company Can-Fite BioPharma on $9.0M Public Offering of ADSs

can-fite biopharma

New York, NY – Press Release – September 22, 2015 –Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Israeli biotechnology company, Can-Fite BioPharma (NYSE: CANF)(TASE: CFBI) on a public offering with institutional investors where Can-Fite received $9 million in gross proceeds. Pursuant to the offering, Can-Fite will issue 2,068,966 registered American Depository Shares (ADSs) at a purchase price of $4.35 per ADS. For each ADS purchased, investors will receive an unregistered warrant to purchase one-half of an ADS at an exercise price of $5.25 per ADS. H.C. Wainwright & Co. acted as the sole placement agent for the offering.

The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Partner Ronen Kantor of the Israeli DTKGC-SRFF office and Gary Emmanuel and Avital Even-Shoshan in New York.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP